Search Tag: Myocardial fibrosis
2024 26 Jun
Mitral valve prolapse (MVP) is a common valvular disease, affecting 2%–3% of the general population and generally having a good prognosis unless accompanied by significant mitral regurgitation or left ventricular (LV) dysfunction. However, some patients with MVP experience sustained ventricular tachycardia (VT) and sudden cardiac death (SCD) despite...Read more
2024 26 Jun
Mitral valve prolapse (MVP) is a common valvular disease, affecting 2%–3% of the general population and generally having a good prognosis unless accompanied by significant mitral regurgitation or left ventricular (LV) dysfunction. However, some patients with MVP experience sustained ventricular tachycardia (VT) and sudden cardiac death (SCD) despite...Read more
2024 26 Jun
Mitral valve prolapse (MVP) is a common valvular disease, affecting 2%–3% of the general population and generally having a good prognosis unless accompanied by significant mitral regurgitation or left ventricular (LV) dysfunction. However, some patients with MVP experience sustained ventricular tachycardia (VT) and sudden cardiac death (SCD) despite...Read more